| Independent Reports (Showing 1 to 6 of 6) |
Release Date ![[down]](http://us.i1.yimg.com/us.yimg.com/i/fi/down.gif) |
Contributor |
Author |
Title |
Pages |
Price |
More Info |
| 21-Nov-09 | Reuters Investment Profile | N/A | Bearclaw Capital Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 | $20 | View Abstract |
| 15-Oct-09 | Global Markets Direct | Global Markets Direct | Bearclaw Capital Corp. Financial Analysis Review | 11 | $300 | View Abstract |
| 30-Mar-09 | Pechala's Reports | Lubomir Pechala | BARR PHARMACEUTICALS INC (BRL=US) - REPORT FOR ACTIVE TRADERS | 4 | $25 | View Abstract |
| 30-Mar-09 | ValuEngine, Inc. | N/A | ValuEngine Industry Report for DRUGS | 18 | $49 | View Abstract |
| 28-Mar-09 | Stock Traders Daily | Thomas H. Kee Jr. | Trading Report for (BRL) Detailed Technical Analysis + Free Market Timing Report | 15 | $18 | View Abstract |
| 26-Dec-08 | ValuEngine, Inc. | N/A | ValuEngine Detailed Valuation Report for BRL | 13 | $25 | View Abstract |